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Liver Biopsy: Is it Safe in Children?
Omayma M Sabir, Ahmed B Ali, Osama Algemaabi.
Abstract
Introduction: The blind liver biopsy technique has been widely used in Sudan as the availability of 
the ultra sound machines and the committed Pediatrics Radiologist were not always at hands. Liver 
biopsy is an essential tool in the diagnosis of liver diseases and subsequently, initiating the 
appropriate treatment.
Objective: The aim of the study was to observe the safety of blind liver biopsy in our children. 
Methods: One hundred fifty consecutive liver biopsies in hospitalized children were evaluated 
retrospectively. Using a standard percussion technique biopsy sites were chosen and through 
intercostals space blind liver biopsies were performed by TruCut biopsy needle. The study was 
conducted at Gafaar Ibn Oaf Specialized Children Hospital ,Khartoum Sudan, over the last five 
years, between January 2005-January 2010 . 
Results: The first biopsy sample was considered macroscopically adequate in 94.8% of cases. A 
definitive histological diagnosis was possible in 99.1% of cases. seventy children were more than 5 
years of age and of these 8 (11.4%) complained of pain at the biopsy site, external hemorrhage from 
the biopsy site was seen in 1 (0.6%) case but no sign of internal hemorrhage was detected during 
the 24 hours follow up period. No child died following the procedure.
Conclusions: Blind liver biopsy in the studied hospitalized children was found to be a safe 
procedure.
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n 1882 Paul Ehrlich first introduced the 
technique of liver biopsy In Germany
1
. 
Later Menghini in 1958 made this 
technique quicker and easier
2
. Liver biopsies 
are the most specific test to assess the nature 
and severity of liver diseases and it provides 
an accurate diagnosis in about 90% of cases 
with unexplained elevation of liver enzymes
3
. 
It not only provides valuable information 
regarding staging, prognosis and management 
of various liver diseases but also is useful in 
monitoring the efficacy of different treatment 
protocols. Percutaneous liver biopsy could be 
blind or image guided. It is debatable whether 
ultrasound (US) guided liver biopsy reduces 
the rate of complication, provides a higher 
diagnostic yield or is cost-effective
4-8
. 
Ultrasound guided liver biopsy is cost-
effective only when the additional charge of 
US is less than US $102
7
. This additional 
charge is a major concern in doing routine
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 US-guided liver biopsy in a developing 
country like Sudan. Moreover there is paucity 
of large series of data regarding the safety of 
blind liver biopsy in children. Most of the 
data that are available in literature are from 
adult studies. The aim of this study was 
therefore to observe the safety of blind liver 
biopsy in children admitted at a pediatric 
gastroenterology unit of a tertiary care 
hospital of a developing country.
Material and Method
All children underwent intercostal 
percutaneous liver biopsies at the Pediatric 
Gastroentrology unit of Gaafar Ibn Oaf
Specialized Children Hospital, Khartoum 
Sudan, between January 2005 through 
January 2010 were evaluated retrospectively. 
All these children were inpatient with various 
liver problems. All the biopsies were 
performed by a Pediatric Gastroenterologist at 
the departmental procedure room. None of the 
children were fasted and no sedation was used 
prior to the procedure. Informed verbal 
consent was obtained from the parents before 
the procedure. Prothrombin times (PT) of all 
I
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the children, except 12, were less than 3 sec. 
greater than the control.
Their platelet counts were more than 1, 
00,000/cram.with normal bleeding and 
clotting time. Twelve children had PT more 
than 3 but less than 6 sec. greater than control 
and liver biopsies in these children were done 
after starting FFP infusion (15ml/kg), 30 
minutes prior to the procedure and continuing 
over the next 2 hours
9
. Pre biopsy US were 
done only for exclusion of focal liver lesion. 
Liver biopsies were not done in children with 
huge ascites, history of lidocaine allergy and 
intake of NSAID within past 7 days. A 
compatible blood-donor was kept in hand and 
all the biopsies were performed with TruCut 
needle (14 Ga. TWx11.4 cm. with 20 mm 
specimen notch
Ameco Medical Industries, Egypt). Keeping 
the patient supine with right arm above the 
head, percussion was done between the 
anterior and mid-axillary line. The point of 
first maximum dullness was chosen while 
percussing caudally beginning under the right 
breast. The biopsy site was marked one space 
below that point in the mid-axillary line. After 
infiltrating 2% lidocaine HC1 a small incision 
was made and biopsy needle was introduced 
cephalic towards the xiphoid process until a 
sudden decrease of resistance was felt. A 
second pass was tried when the first sample 
was considered inadequate (length <0.5cm.), 
but after 2 un-successful attempts the 
procedure was suspended for the next week. 
After the procedure all the children were kept 
in right lateral position for at least 4 hours 
followed by a posture of choice. Vital signs 
like pulse and blood pressure were monitored 
every 15 minutes for the first one hour, every 
30 minutes for the next 3 hours and hourly for 
the subsequent 20 hours. Examinations of 
abdomen and chest were also done during this 
follow up period. 
Results 
Liver biopsies were done in 150 children of 
which 102 (68%) were male. The ages of the 
children varied from 1 month 23 days to 15 
years (mean 6.77±4.26yrs). Cholestatic 
jaundice (50%) and hepatomegaly (24%) 
were the two main indications for doing liver 
biopsy (Table1).
Table1: Indications for liver biopsy.
Name of Primary condition No (%)
Cholestatic jaundice 75  (50%)
Hepatomegaly 36  (24%)
Portal Hypertension 24  (16%)
Auto Immune Hepatitis 8    (5.3%)
Wilson Disease 4    (2.6%)
Hepatic Neoplasm 3    (2%)
In 141 of 150 children (94%) the first biopsy 
sample was considered macroscopically 
adequate (>0.5cm). In 6 children (4%) the 
second attempt was successful and in the 
remaining 3 (2%) the procedure was 
suspended after 2 consecutive attempts and 
their biopsies were done one week later. A 
definitive histological diagnosis was possible 
in 148 cases (99%) and these are shown in 
table 2.






Billary Atresia 6  (4%)
Bile Duct Paucity 3  (2%)
Hebatoblastoma 3  (2%)
Sixty children (40%) were below 5 years of 
age and excessive crying and/or irritability 
were their main complaints following the 
procedure. ninety children were more than 5 
years of age and of these 10 (11%) 
complained of pain at the biopsy site. In 
addition to the local pain, 6 children (4%) 
also complained of right shoulder pain. No 
intervention other than oral paracetamol was 
required in these children. External 
hemorrhage from the biopsy site was seen in 
1 (0.6%) child that did not require any 
intervention other than maintenance of 
posture in right lateral position. All the 
children were kept inpatient for 24 hours and 
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thorough physical examination during this 
period did not detect any sign of internal 
hemorrhage, peritonitis, perforation, 
pneumothorax, etc. No child died following 
the procedure.
Discussion   
Liver biopsy is usually performed after a 
thorough non-invasive clinical evaluation. It 
is a safe procedure when performed by an 
experienced operator. Froehlich et al
10
 noted 
a lower complication rate for physicians who 
performed more than 50 biopsies a year. In 
another study logistic regression analysis 
identified age (<0.0005), presence of 
malignancy (p<0.0001), pre-biopsy 
hemoglobin concentration (p<0.005) and 
number of passes (p<0.001) as univariately 
associated with complication
11
. In few studies 
lower complication rate and higher diagnostic 
yield were demonstrated in US guided 
biopsies compared to blind technique
6,12
. On 
the contrary a British survey found that 
complications could not be avoided by the use 
of US guided technique
5
. In the present series 
all the biopsies were done blindly (without 
US guide) and a definitive histological 
diagnosis was possible in 99.1% of cases. 
Using the blind technique the overall 
accuracy of liver biopsy in diagnosing hepatic 





. On the contrary Caturelli 
et al
6
, by using US guide, were able to come 
to a pathological diagnosis in 99.4% of their 
cases. Therefore, the result of the present 
report is comparable to that of a guided series. 
The macroscopic size of the biopsy specimen 
in the present series was found adequate in 
94.8% of cases at first and in 98.3% cases at 
the end of 2
nd
 attempt. In consistent with 
these, the findings of a guided biopsy series 
were 92.4% and 99.6% respectively
6
.
About 60% of complications occurred within 
2 and 96% within 24 hours following the 
procedure
1,15
. Pain is the commonest post-
biopsy complain and it was perceived by 25% 
of adult patients who had non-guided 
compared to 22% of patients who had guided 
biopsies
16
. Forty percent of children in the 
present report were below 5 years of age and 
they could not specifically mention the exact 
site and nature of pain/discomfort following 
the procedure but excessive crying/irritability 
were their main post-biopsy complaints. It is 
assumed that it could be due either to pain or 
fear of the procedure. In the older age group
(>5 years) 10% of 90 children complained of 
pain following the procedure and this figure is 
lower than the report of a British survey
16
. 
Bleeding following liver biopsy is not 
uncommon and it was reported in 1.6% of 
cases following a non-guided and in 2.5% 
cases following a guided procedure, but these 
figures are not statistically significant
16
. Three 
types of bleeding may occur following liver 
biopsy: (a) Free intra-peritoneal, (b) Intra-
hepatic and/or sub-capsular hematoma and (c) 
Hemobilia. Free intra-peritoneal hemorrhage 
can be recognized by imaging studies and in a 
study of 108 liver biopsies routine US 
examination of abdomen done 2-4hours after 
the procedure detected free fluid in 6% cases 
with no clinical consequences
17
. Small sub-
capsular/intra-hepatic hematoma is usually 
asymptomatic but large hematoma may cause 
pain, tachycardia, hypotension or drop in 
hematocrit. In one series symptomatic sub-
capsular hematoma was observed in only 3 of 
12,750 (0.023%) biopsies
18
. Hemobilia is the 
least common type of hemorrhage and in a 
series of 68,276 percutaneous biopsies only 4 
cases (0.006%) of hemobilia were detected
15
. 
Therefore, it is assumed that chance of post-
biopsy internal hemorrhage is negligible and 
routine US is not usually required following 
the procedure. In the present series no post-
procedure US was done but all the children 
were kept inpatient for 24 hours and close 
monitoring of these children did not detect 
any sign of internal hemorrhage. Only one 
case of external hemorrhage from the 
punctured site was observed and the case was 
managed conservatively by keeping the child 
in right lateral position.
Liver biopsy has a mortality of 0.01-
0.1%
12,15
. Death is usually due to bleeding or 
biliary peritonitis as a result of puncture of the 
gall bladder. Incidence of bleeding is 
probably proportional to the incidence of 
formation of hematoma, which is not 
influenced by the use of US
19
. Ultrasound 
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guided biopsy may be expected to reduce the 
risk of puncture of gall bladder, but no 
randomized control trial has been large 
enough to show reduced mortality with 
ultrasonography
5
. In the present series no 
child died following the procedure.
Prothrombin time is an important 
hematological test routinely done before 
biopsy and in most of the series liver biopsies 
were done when it was less than 3-5 seconds 
of the upper limit of normal
11,20
. In the 
present series there were 12 children whose 
PT were elevated and liver biopsies were 
done in them by infusing FFP. No signs of 
internal or external hemorrhage were detected 
in these children during the 24 hours follow 
up period. It may be mentioned here that 
during the follow up period a matched donor 
was kept in hand.
It is summarized that blind liver biopsy was 
found safe and diagnostic in the present series 
and it was also found safe in a small group of 
children with mild elevation of PT where the 
procedures were done with infusion of FFP.
Conclusions
Blind liver biopsy in children is a safe 
procedure in an inpatient setting when it is 
done by an experienced operator. It is 
economic, easy, useful and essential to 
diagnose different liver diseases. 
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